Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Rockwell Medical (RMTI) over the last 11 years, with Q3 2025 value amounting to $3.0 million.

  • Rockwell Medical's Change in Acquisitions & Divestments changed N/A to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 4992.5%. This contributed to the annual value of $2.0 million for FY2024, which is 8690.94% down from last year.
  • Rockwell Medical's Change in Acquisitions & Divestments amounted to $3.0 million in Q3 2025.
  • Rockwell Medical's 5-year Change in Acquisitions & Divestments high stood at $12.0 million for Q1 2022, and its period low was $1.8 million during Q2 2023.
  • Over the past 5 years, Rockwell Medical's median Change in Acquisitions & Divestments value was $4.1 million (recorded in 2021), while the average stood at $5.2 million.
  • In the last 5 years, Rockwell Medical's Change in Acquisitions & Divestments crashed by 5714.58% in 2021 and then skyrocketed by 7767.88% in 2022.
  • Rockwell Medical's Change in Acquisitions & Divestments (Quarter) stood at $7.6 million in 2021, then fell by 5.19% to $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then plummeted by 49.92% to $2.0 million in 2024, then skyrocketed by 49.78% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $3.0 million for Q2 2025, and $3.0 million during Q1 2025.